Ticker
BTAICompany Name
BIOXCEL THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Current Assets | Inventory | Current Liabilities | Quick Ratio |
---|---|---|---|---|
6/30/2025 | $ 25.24M | $ 506K | $ 33.38M | 0.74 |
3/31/2025 | $ 37.78M | $ 642K | $ 25.55M | 1.45 |
12/31/2024 | $ 37.39M | $ 679K | $ 22.23M | 1.65 |
9/30/2024 | $ 47.79M | $ 1.52M | $ 25.56M | 1.81 |
6/30/2024 | $ 64.18M | $ 2.68M | $ 27.29M | 2.25 |
3/31/2024 | $ 80.92M | $ 2.44M | $ 31.48M | 2.49 |
12/31/2023 | $ 72.14M | $ 1.99M | $ 27.27M | 2.57 |
9/30/2023 | $ 98.74M | $ 2.02M | $ 39.41M | 2.45 |
6/30/2023 | $ 138.24M | $ 1.93M | $ 34.74M | 3.92 |
3/31/2023 | $ 177.27M | $ 1.95M | $ 28.76M | 6.1 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(AssetsC - Inventory) / LiabilitesC
(=) Quick Ratio
Quick Ratio for BIOXCEL THERAPEUTICS INC is calculated as follows: (AssetsC [ $ 236.13M ] - Inventory [ $ 0 ]) / LiabilitesC [ $ 16.34M ]
(=) Quick Ratio [ 14.45 ]
Minimum
Jun 30, 2025
Maximum
Jun 30, 2021
Average
Median
filtered constituents | 3.12K |
---|---|
min | -0.73 |
max | 5.45 |
average | 1.55 |
median | 1.23 |
std | 1.17 |